Bicyclic compound and use thereof
US-2022402902-A1 · Dec 22, 2022 · US
This page is not indexed by search engines while we improve data quality.
Sk Biopharmaceuticals Co Ltd patents in 2022
Sk Biopharmaceuticals Co Ltd was listed as an assignee on 14 patent publications in 2022.
| Metric | Value |
|---|---|
| Company | Sk Biopharmaceuticals Co Ltd |
| Year | 2022 |
| Patents | 14 |
Patents
Representative publications for Sk Biopharmaceuticals Co Ltd in 2022.
Methods for treating attention-deficit/hyperactivity disorder
US-11524935-B2 · Dec 13, 2022 · US
Use of imidazopyrimidine or imidazotriazine compound for prevention, alleviation, or treatment of developmental disability
US-2022387429-A1 · Dec 8, 2022 · US
Use of imidazopyrimidine or imidazotriazine compounds for prevention, alleviation, or treatment of cognitive disorders, or for improving cognitive function
US-2022370461-A1 · Nov 24, 2022 · US
Treatment for obesity
US-11497725-B2 · Nov 15, 2022 · US
Top CPC classifications
Most common classification codes for Sk Biopharmaceuticals Co Ltd in 2022.
Related pages
Navigate to parent entity pages.